specialty pipeline

In the News: Specialty Drugs Fill 2017 Pipeline

New therapies to treat inflammatory conditions, multiple sclerosis, and cancer are among the products highlighted in Express Scripts’ Specialty Pipeline report. In 2016, specialty drugs made up 71% of the 24 drugs approved by the FDA last year. That trend is expected to continue, with specialty drugs, including therapies for orphan diseases, dominating the 2017 pipeline.

Subscribe to RSS - specialty pipeline